These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1346069)

  • 21. Role of human immunodeficiency virus (HIV)-specific T-cell immunity in control of dual HIV-1 and HIV-2 infection.
    Zheng NN; McElrath MJ; Sow PS; Hawes SE; Diallo-Agne H; Stern JE; Li F; Mesher AL; Robinson AD; Gottlieb GS; Huang Y; Kiviat NB
    J Virol; 2007 Sep; 81(17):9061-71. PubMed ID: 17582003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infection of Epstein-Barr virus-transformed lymphoblastoid B cells by the human immunodeficiency virus: evidence for a persistent and productive infection leading to B cell phenotypic changes.
    De Rossi A; Roncella S; Calabro ML; D'Andrea E; Pasti M; Panozzo M; Mammano F; Ferrarini M; Chieco-Bianchi L
    Eur J Immunol; 1990 Sep; 20(9):2041-9. PubMed ID: 2170147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of pseudotype formation between human immunodeficiency virus type 1 and Epstein-Barr virus in productively coinfected B lymphoblastoid cell lines.
    Van Kuyk R; Mosier DE
    Virology; 1995 Jun; 209(2):643-8. PubMed ID: 7778296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A chimpanzee-passaged human immunodeficiency virus isolate is cytopathic for chimpanzee cells but does not induce disease.
    Watanabe M; Ringler DJ; Fultz PN; MacKey JJ; Boyson JE; Levine CG; Letvin NL
    J Virol; 1991 Jun; 65(6):3344-8. PubMed ID: 1674550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.
    Kaiser P; Joos B; Niederöst B; Weber R; Günthard HF; Fischer M
    J Virol; 2007 Sep; 81(18):9693-706. PubMed ID: 17609262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transfection of a retroviral construct carrying a non producer HIV-1 variant induces HIV-1 resistance in CD4+ CEMss cells.
    Federico M; Taddeo B; Nappi F; Nicolini A; Rossi GB; Verani P
    J Biol Regul Homeost Agents; 1993; 7(2):41-9. PubMed ID: 7903507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biologic heterogeneity of human immunodeficiency virus type 2 (HIV-2) strains.
    Castro BA; Barnett SW; Evans LA; Moreau J; Odehouri K; Levy JA
    Virology; 1990 Oct; 178(2):527-34. PubMed ID: 2120848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of human leukocyte antigen class I molecules in human immunodeficiency virus infection of CD4-positive cells.
    Benkirane M; Blanc-Zouaoui D; Hirn M; Devaux C
    J Virol; 1994 Oct; 68(10):6332-9. PubMed ID: 7916059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human endothelial cells enhance human immunodeficiency virus type 1 replication in CD4+ T cells in a Nef-dependent manner in vitro and in vivo.
    Choi J; Walker J; Boichuk S; Kirkiles-Smith N; Torpey N; Pober JS; Alexander L
    J Virol; 2005 Jan; 79(1):264-76. PubMed ID: 15596822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin 2 induces CD8+ T cell-mediated suppression of human immunodeficiency virus replication in CD4+ T cells and this effect overrides its ability to stimulate virus expression.
    Kinter AL; Bende SM; Hardy EC; Jackson R; Fauci AS
    Proc Natl Acad Sci U S A; 1995 Nov; 92(24):10985-9. PubMed ID: 7479922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human immunodeficiency virus pseudotypes with expanded cellular and species tropism.
    Spector DH; Wade E; Wright DA; Koval V; Clark C; Jaquish D; Spector SA
    J Virol; 1990 May; 64(5):2298-308. PubMed ID: 1691314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular cloning, expression, and biological characterization of an HTLV-II envelope glycoprotein: HIV-1 expression is permissive for HTLV-II-induced cell fusion.
    Wang B; Agadjanyan MG; Srikantan V; Ugen KE; Hall W; Kaplan MH; Dang K; Williams WV; Weiner DB
    AIDS Res Hum Retroviruses; 1993 Sep; 9(9):849-60. PubMed ID: 8257634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of human immunodeficiency virus type 1 (HIV-1) replication and accumulation of viral DNA in HIV-1-infected T cells blocked in cell replication.
    Tang S; Poulin L; Levy JA
    J Gen Virol; 1992 Apr; 73 ( Pt 4)():933-9. PubMed ID: 1634879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human immunodeficiency virus type 1 (HIV-1) antigen secretion by latently infected resting CD4+ T lymphocytes from HIV-1-infected individuals.
    Fondere JM; Petitjean G; Huguet MF; Salhi SL; Baillat V; Macura-Biegun A; Becquart P; Reynes J; Vendrell JP
    J Virol; 2004 Oct; 78(19):10536-42. PubMed ID: 15367620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of a CD4-expressing macaque cell line that can detect virus after a single replication cycle and can be infected by diverse simian immunodeficiency virus isolates.
    Chackerian B; Haigwood NL; Overbaugh J
    Virology; 1995 Nov; 213(2):386-94. PubMed ID: 7491763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential response to the cytopathic effects of human T-cell lymphotropic virus type III (HTLV-III) superinfection in T4+ (helper) and T8+ (suppressor) T-cell clones transformed by HTLV-I.
    De Rossi A; Franchini G; Aldovini A; Del Mistro A; Chieco-Bianchi L; Gallo RC; Wong-Staal F
    Proc Natl Acad Sci U S A; 1986 Jun; 83(12):4297-301. PubMed ID: 2424024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytopathic variants of an attenuated isolate of human immunodeficiency virus type 2 exhibit increased affinity for CD4.
    Hoxie JA; Brass LF; Pletcher CH; Haggarty BS; Hahn BH
    J Virol; 1991 Sep; 65(9):5096-101. PubMed ID: 1870213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Membrane-fusing capacity of the human immunodeficiency virus envelope proteins determines the efficiency of CD+ T-cell depletion in macaques infected by a simian-human immunodeficiency virus.
    Etemad-Moghadam B; Rhone D; Steenbeke T; Sun Y; Manola J; Gelman R; Fanton JW; Racz P; Tenner-Racz K; Axthelm MK; Letvin NL; Sodroski J
    J Virol; 2001 Jun; 75(12):5646-55. PubMed ID: 11356972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Replicative capacity of HIV-2, like HIV-1, correlates with severity of immunodeficiency.
    Albert J; Nauclér A; Böttiger B; Broliden PA; Albino P; Ouattara SA; Björkegren C; Valentin A; Biberfeld G; Fenyö EM
    AIDS; 1990 Apr; 4(4):291-5. PubMed ID: 2190603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation.
    McNeil AC; Shupert WL; Iyasere CA; Hallahan CW; Mican JA; Davey RT; Connors M
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13878-83. PubMed ID: 11717444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.